What is Vida Diagnostics?
VIDA Diagnostics is at the forefront of revolutionizing lung and respiratory care. The company empowers healthcare organizations and physicians with a comprehensive approach that leverages quantitative data intelligence and impactful visualizations. This technology is crucial for managing patients with or at risk of chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and COVID-19, thereby driving improved patient outcomes, streamlining care coordination, and boosting overall efficiencies. The company's commitment to proven quality and clinical leadership positions it as a key player in the health tech sector.
How much funding has Vida Diagnostics raised?
Vida Diagnostics has raised a total of $10.1M across 4 funding rounds:
Other Financing Round
$2.5M
Series B
$5.1M
Other Financing Round
$500K
Series C
$2M
Other Financing Round (2014): $2.5M with participation from Next Level Ventures
Series B (2016): $5.1M led by Chartline Capital Management, Next Level Ventures, Rittenhouse Ventures, and Iowa Seed Fund
Other Financing Round (2019): $500K supported by Iowa Innovation Acceleration Fund
Series C (2020): $2M featuring OSF Ventures
Key Investors in Vida Diagnostics
Next Level Ventures
Next Level Ventures is a prominent investment firm based in Iowa, specializing in strategic investments from seed to growth stages. They actively support portfolio companies with financial, operational, and networking assistance, aiming to deliver profitable outcomes and contribute to the innovation ecosystem.
Chartline Capital Management
Chartline B2B Venture Investors is a venture capital fund focused on enterprise and industrial technology, providing funding to help founders scale their businesses efficiently and emphasizing a partnership approach.
Rittenhouse Ventures
Rittenhouse Ventures is a Philadelphia-based venture capital firm specializing in early-stage investments in technology businesses, particularly in healthcare technology and digital media analytics, providing tailored investments and strategic support.
What's next for Vida Diagnostics?
With the recent influx of enterprise-level capital, Vida Diagnostics is poised for accelerated growth and expanded market penetration. The company's strategic objective will likely involve further development of its data intelligence platform, enhancing its visualization tools, and broadening its clinical applications. This investment will also support efforts to scale operations, forge new partnerships within the healthcare ecosystem, and potentially explore new therapeutic areas or diagnostic capabilities. The sustained backing indicates strong investor confidence in VIDA's mission to transform respiratory care through advanced technology and data-driven insights.
See full Vida Diagnostics company page
